Ligand validation:8BSZ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8BSZ_NAG_A_501	17%	83%	0.227	0.802	0.28	0.49	-	-	0	0	100%	1
4UZQ_NAG_A_1452	95%	46%	0.068	0.971	0.74	1.33	-	2	0	0	100%	1
4UZ1_NAG_A_1453	78%	58%	0.089	0.931	0.67	0.94	-	1	0	0	100%	1
7BMD_NAG_A_616	60%	87%	0.137	0.923	0.24	0.44	-	-	0	0	100%	1
4UZ6_NAG_A_1452	59%	39%	0.096	0.876	0.88	1.5	1	3	0	0	100%	1
4UZ9_NAG_A_1452	53%	50%	0.111	0.87	0.94	0.98	-	-	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.